Why FTSE 100 growth stock NMC Health could trash the GSK share price
Why FTSE 100 growth stock NMC Health could trash the GSK share price. The share price of Abu Dhabi-based healthcare centre operator NMC Health (LSE: NMC) rose by 5% in early trading this morning after the firm said that its 2018 profits would be higher than expected. Full-year revenue is now expected to rise by 24%, up from previous guidance of 22%. And full-year earnings before interest, tax, depreciation and amortisation (EBITDA) are now expected to be $480m, 3.2% above previous guidance of $465m. It’s good news for shareholders, who’ve seen the value of their stock fall by more than 25% from August’s all-time high of 4,376p. But NMC shares aren’t cheap.